This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive molecules. Its structure, featuring a benzyl group and a trifluoromethyl substituent, makes it valuable for developing drugs with enhanced pharmacokinetic properties. It is often employed in the creation of central nervous system (CNS) agents, where the trifluoromethyl group can improve metabolic stability and bioavailability. Additionally, it serves as a building block in the design of potential therapeutic compounds targeting neurological disorders, such as anxiety, depression, and neurodegenerative diseases. Its versatility also extends to its use in medicinal chemistry research for exploring novel drug candidates with improved efficacy and selectivity.